FS KKR Capital Corp. FSK 深 沪
等待开盘 02-10 09:30:00 美东时间
13.14
+0.280
+2.18%
华盛通- 最 高13.195
- 今 开12.85
- 成交量 198.21万股
- 最 低 12.80
- 昨 收 12.86
- 总市值 36.80亿
- 52周最高 21.30
- 市盈率 静 6.29
- 换手率 0.71%
- 52周最低 12.65
- 委 比 0.00%
- 总股本 2.80亿
- 历史最高 21.30
- 量 比 0.56
- 振 幅 3.07%
- 历史最低 -7.98
- 每 手 1
- 风险率 2.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FS KKR Capital Corp. announces earnings release and conference call schedule
FS KKR Capital Corp. announces earnings release and conference call schedule FS KKR Capital Corp. will release its fourth quarter and full year 2025 results after the close of trading on the New York Stock Exchange on Wednesday, February 25, 2026. Results will be available in the For Investors secti
01-22 05:27
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
Keefe, Bruyette & Woods Maintains Market Perform on FS KKR Capital, Lowers Price Target to $18
Keefe, Bruyette & Woods analyst Paul Johnson maintains FS KKR Capital (NYSE:FSK) with a Market Perform and lowers the price target from $18.5 to $18.
2025-11-11 01:30
CORRECTION: FS KKR Capital Q3 Adj. EPS $0.57 Misses $0.58 Estimate, Sales $373.000M Miss $374.893M Estimate
FS KKR Capital (NYSE:FSK) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.58 by 1.21 percent. This is a 22.97 percent decrease over earnings of $0.74 per share from the
2025-11-06 06:44
美股大行评级 | 潜在涨幅4347.41%！Ascendiant Capital上调PAVmed目标价至20美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从19美元升至20美元；Ascendiant Capital：维持Plus Therapeutics"买入"评级，目标价从20.5美元升至21美元
2025-10-07 15:04
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
2025-10-02 15:08
JP Morgan Maintains Neutral on FS KKR Capital, Lowers Price Target to $15
JP Morgan analyst Richard Shane maintains FS KKR Capital (NYSE:FSK) with a Neutral and lowers the price target from $18 to $15.
2025-10-01 22:40
